Literature DB >> 29388835

Polymorphonuclear Leukocytes in Pulmonary Hypertension and Fibrosis: Not Always What They Appear to Be.

Nedim Durmus1, Gabriele Grunig1,2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29388835      PMCID： PMC5806001          DOI： 10.1165/rcmb.2017-0336ED

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN： 1044-1549            Impact factor:   6.914


× No keyword cloud information.
  19 in total

Review 1.  Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots.

Authors:  Steven D Nathan; Paul W Noble; Rubin M Tuder
Journal:  Am J Respir Crit Care Med       Date:  2007-01-25       Impact factor: 21.405

2.  Peripheral blood myeloid-derived suppressor cells reflect disease status in idiopathic pulmonary fibrosis.

Authors:  Isis E Fernandez; Flavia R Greiffo; Marion Frankenberger; Julia Bandres; Katharina Heinzelmann; Claus Neurohr; Rudolf Hatz; Dominik Hartl; Jürgen Behr; Oliver Eickelberg
Journal:  Eur Respir J       Date:  2016-09-01       Impact factor: 16.671

3.  Attenuation of leukocyte recruitment via CXCR1/2 inhibition stops the progression of PAH in mice with genetic ablation of endothelial BMPR-II.

Authors:  Victoria J Burton; Alan M Holmes; Loredana I Ciuclan; Alexander Robinson; Jan S Roger; Gabor Jarai; Andrew C Pearce; David C Budd
Journal:  Blood       Date:  2011-09-07       Impact factor: 22.113

Review 4.  Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected.

Authors:  Douglas Marvel; Dmitry I Gabrilovich
Journal:  J Clin Invest       Date:  2015-07-13       Impact factor: 14.808

5.  Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients.

Authors:  Thomas Condamine; George A Dominguez; Je-In Youn; Andrew V Kossenkov; Sridevi Mony; Kevin Alicea-Torres; Evgenii Tcyganov; Ayumi Hashimoto; Yulia Nefedova; Cindy Lin; Simona Partlova; Alfred Garfall; Dan T Vogl; Xiaowei Xu; Stella C Knight; George Malietzis; Gui Han Lee; Evgeniy Eruslanov; Steven M Albelda; Xianwei Wang; Jawahar L Mehta; Meenakshi Bewtra; Anil Rustgi; Neil Hockstein; Robert Witt; Gregory Masters; Brian Nam; Denis Smirnov; Manuel A Sepulveda; Dmitry I Gabrilovich
Journal:  Sci Immunol       Date:  2016-08-05

6.  Myeloid-derived Suppressor Cells Are Necessary for Development of Pulmonary Hypertension.

Authors:  Andrew J Bryant; Vinayak Shenoy; Chunhua Fu; George Marek; Kyle J Lorentsen; Erica L Herzog; Mark L Brantly; Dorina Avram; Edward W Scott
Journal:  Am J Respir Cell Mol Biol       Date:  2018-02       Impact factor: 6.914

7.  A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-gamma.

Authors:  R L Coffman; J Carty
Journal:  J Immunol       Date:  1986-02-01       Impact factor: 5.422

8.  Diesel exhaust particle induction of IL-17A contributes to severe asthma.

Authors:  Eric B Brandt; Melinda Butsch Kovacic; Gerald B Lee; Aaron M Gibson; Thomas H Acciani; Timothy D Le Cras; Patrick H Ryan; Alison L Budelsky; Gurjit K Khurana Hershey
Journal:  J Allergy Clin Immunol       Date:  2013-09-20       Impact factor: 10.793

Review 9.  Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards.

Authors:  Vincenzo Bronte; Sven Brandau; Shu-Hsia Chen; Mario P Colombo; Alan B Frey; Tim F Greten; Susanna Mandruzzato; Peter J Murray; Augusto Ochoa; Suzanne Ostrand-Rosenberg; Paulo C Rodriguez; Antonio Sica; Viktor Umansky; Robert H Vonderheide; Dmitry I Gabrilovich
Journal:  Nat Commun       Date:  2016-07-06       Impact factor: 14.919

10.  HIF2α-arginase axis is essential for the development of pulmonary hypertension.

Authors:  Andrew S Cowburn; Alexi Crosby; David Macias; Cristina Branco; Renato D D R Colaço; Mark Southwood; Mark Toshner; Laura E Crotty Alexander; Nicholas W Morrell; Edwin R Chilvers; Randall S Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-18       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.